News | April 06, 2026
Samsung Biologics lands first US manufacturing facility with GSK acquisition
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The center brings together hands on technology demonstrations, application expertise, and commercial operations
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The inspection is now closed, and no regulatory action has been recommended
The presentations underscore the company’s deep expertise in dermatology and immunology
Subscribe To Our Newsletter & Stay Updated
